.png)
Semaglutide isn’t just a weight loss drug — it’s a molecule that mimics a hormone your body makes naturally, and resets the physiological environment that has been making weight loss difficult. Here’s the actual science.
March 18, 2026
When your body perceives a caloric deficit, it doesn’t quietly accept it. It activates a coordinated physiological response — elevating ghrelin (the hunger hormone), slowing metabolic rate, reducing the energy available for non-essential functions, and increasing the reward value of high-calorie foods in the brain. This is why most people who lose weight through restriction regain it: the body treats the deficit as a threat and works systematically to reverse it. Semaglutide works by intervening in this system at the hormonal level — not by creating a deficit by force, but by changing the signals that determine how hungry you are in the first place.
At Modern Wellness Clinic in Summerlin, Las Vegas, semaglutide is prescribed as part of a physician-supervised program that includes labs, monitoring, and integration with any other hormonal or metabolic treatment the patient needs. Here’s how it actually works.
GLP-1 stands for glucagon-like peptide-1. It’s a hormone produced in the cells of your small intestine in response to eating. Its biological role is significant: it signals the pancreas to release insulin in proportion to blood sugar (called glucose-dependent insulin secretion), it suppresses glucagon release (which would otherwise drive blood sugar up), it slows gastric emptying (so food moves through your digestive system more slowly), and it acts directly on receptors in the brain to register satiety and reduce appetite.
In people with obesity, insulin resistance, or type 2 diabetes, this GLP-1 response is often blunted — meaning the hormonal signal that should be regulating appetite and blood sugar isn’t working the way it should. Semaglutide is a GLP-1 receptor agonist: a synthetic molecule designed to bind to GLP-1 receptors and activate them more potently and persistently than the natural hormone does.
When semaglutide binds to GLP-1 receptors, several things happen simultaneously. In the pancreas, it stimulates insulin secretion in response to blood glucose — improving blood sugar control without the risk of hypoglycemia that comes with insulin injections. In the stomach, it slows the rate at which food moves into the small intestine, which extends the feeling of fullness after meals and blunts the post-meal blood sugar spike.
In the brain — and this is the most important piece for weight loss — semaglutide activates GLP-1 receptors in the hypothalamus and brainstem that are directly involved in appetite regulation and the reward value of food. The result: food becomes genuinely less appealing. The urge to eat — particularly between meals, and for high-calorie, highly palatable foods — decreases meaningfully. Patients consistently describe it as the noise around food going quiet.
In the STEP 1 clinical trial, participants using semaglutide 2.4mg weekly lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% in the placebo group. The STEP 4 trial showed that patients who stopped semaglutide regained most of their lost weight within a year, confirming that the medication works while you take it — and that the biological problem it’s addressing is ongoing, not cured. Secondary outcomes across the STEP trials showed meaningful improvements in blood pressure, lipids, blood sugar, and inflammatory markers.
Tirzepatide — which activates both GLP-1 and GIP receptors — produces even more significant weight loss in clinical trials, with some patients losing over 20% of body weight. See our full comparison: Semaglutide vs. Tirzepatide: Which Is Better?
Semaglutide is evaluated for adults with a BMI of 30+, or 27+ with a weight-related medical condition. At Modern Wellness Clinic, evaluation goes beyond BMI — we assess metabolic health, hormonal status, thyroid function, and any contributing conditions before recommending a protocol. For some patients, combining semaglutide with testosterone optimization or BHRT produces significantly better outcomes than semaglutide alone.
There are contraindications that must be screened before prescribing, including personal or family history of medullary thyroid carcinoma and MEN2 syndrome. This evaluation is not a formality — it’s standard clinical practice. Telehealth consultations available statewide across Nevada. Call (702) 463-9159 or schedule at 5375 S Fort Apache Rd, Summerlin, Las Vegas, NV 89148. See our full semaglutide service page for program details.
.png)